Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Profit After Tax: 2011-2025

Historic Profit After Tax for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to -$81.9 million.

  • Enanta Pharmaceuticals' Profit After Tax rose 35.12% to -$18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$81.9 million, marking a year-over-year increase of 29.43%. This contributed to the annual value of -$81.9 million for FY2025, which is 29.43% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Profit After Tax of -$81.9 million as of FY2025, which was up 29.43% from -$116.0 million recorded in FY2024.
  • In the past 5 years, Enanta Pharmaceuticals' Profit After Tax ranged from a high of -$79.0 million in FY2021 and a low of -$133.8 million during FY2023.
  • Moreover, its 3-year median value for Profit After Tax was -$116.0 million (2024), whereas its average is -$110.6 million.
  • As far as peak fluctuations go, Enanta Pharmaceuticals' Profit After Tax plummeted by 118.41% in 2021, and later grew by 29.43% in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Profit After Tax (Yearly) stood at -$79.0 million in 2021, then plummeted by 54.13% to -$121.8 million in 2022, then fell by 9.91% to -$133.8 million in 2023, then rose by 13.28% to -$116.0 million in 2024, then increased by 29.43% to -$81.9 million in 2025.